- French soldier stabbed while on patrol near Paris
- REPEAT-Will immigration reform get killed in Republican-led U.S. House?
- Planetary alignment peaks with celestial show this weekend
- Rockets hit south Beirut after Hezbollah vows Syria victory
- Two believed dead as heavy rains flood San Antonio streets |
Nasal Therapeutics to Enter Migraine Headache Market With New Migraine Relief Homeopathic...
Nasal Therapeutics to Enter Migraine Headache Market With New Migraine Relief Homeopathic Nasal Spray LOS ANGELES, Dec. 4 /PRNewswire/ -- Nasal Therapeutics, Inc. announced today plans to enter the over-the-counter market with a new migraine relief homeopathic nasal spray. The nasal spray is scheduled to hit the shelves in the spring of 2008. Nasal Therapeutics, Inc., a subsidiary of Hensley Group, will launch a line of homeopathic nasal sprays over the next year which will include remedies for allergy, cold and flu. "There are approximately thirty million migraine sufferers in the United States alone", commented Dr. Charles Hensley, Inventor of Zicam Cold Remedy and Chairman of Hensley Group. "Migraine attacks are severe, come on suddenly and are often debilitating. Nasal sprays are the delivery system of choice when it comes to conditions that require rapid relief as they work much faster than oral formulations." "The development of the technology behind the new migraine product was actually quite serendipitous", added Hensley. "While working with intracellular mediators involved in the development of common colds, our scientists discovered that these same compounds are putative causative factors in the genesis and maintenance of migraine attacks. Since they were already developing nasal delivery compounds to address this therapeutic target, it was a natural to pursue a therapy for migraine attack," he continued. About Nasal Therapeutics Nasal Therapeutics develops and markets homeopathic nasal sprays for such conditions as common cold, influenza, allergy and migraine. The company is based on the concept that nasal delivery is the fastest, most effective way to deliver over-the-counter medicines to the site of therapeutic action. Nasal therapeutics was incorporated in 2007 and is in the process of closing its first round of financing. For further information please contact: Investor Relations at email@example.com About Hensley Group Hensley Group controls a diverse group of subsidiary companies engaged in Pharmaceuticals, Biotechnology, Cosmetics, Consulting, Media Marketing and Entertainment and has offices in Los Angeles, Hong Kong, Shanghai and Tokyo. SOURCE Nasal Therapeutics, Inc. Natasha Nelson of NN Public Relations, +1-949-548-2227, Natasha@nnpublicrelations.com, for Nasal Therapeutics, Inc.